Onsemi has put more money on the table, and that changes the negotiating math for everyone involved. The semiconductor company agreed to acquire Synaptics for $123 per share in cash under a revised merger agreement, lifting the value of the previously announced transaction and putting a sharper premium on execution.

For Synaptics shareholders, the message is straightforward: the revised terms offer a higher cash value for each $SYNA share than the earlier agreement. For Onsemi investors, however, the key question is whether paying more can still create value quickly. Management’s answer is that the revised deal is designed to deliver immediate earnings-per-share accretion—a claim that makes the transaction more than a simple purchase-price increase.

The companies jointly announced the revised agreement on October 1. The official announcement describes the $123-per-share offer as an all-cash transaction and emphasizes the objective of providing greater value to Onsemi shareholders through immediate EPS accretion.

What the Higher Offer Means for Synaptics

A cash offer provides Synaptics shareholders with a defined per-share consideration: $123 in cash under the revised terms. Unlike a stock-based transaction, the consideration is not described as depending on the future value of Onsemi equity. That makes the headline economics easier to analyze and gives shareholders a clear reference point when weighing the revised agreement.

The increase over the previously announced transaction terms is the central development. Onsemi is paying more to secure the deal, while Synaptics holders receive a higher stated value. That adjustment may indicate that the parties concluded the original terms no longer represented the appropriate balance between Synaptics’ value and Onsemi’s strategic objectives. It also demonstrates that deal terms can remain economically fluid even after a transaction has been announced.

Why Onsemi Investors Should Focus on Accretion

For Onsemi shareholders, the purchase price is only half the equation. The other half is what the combined business may contribute to earnings. By stating that the revised agreement is intended to produce immediate EPS accretion, management is making a specific financial case for accepting the higher price.

Immediate accretion matters because it frames the acquisition as one that may support earnings from the outset rather than requiring a long period of hoped-for benefits. Still, the statement is an objective, not a reported result. Investors must distinguish between management’s intended outcome and the earnings performance ultimately delivered after the transaction. The revised price raises the burden of proof: the more Onsemi pays, the more important the promised earnings contribution becomes.

The Merger-Arbitrage Lens

For merger-arbitrage traders, an all-cash structure creates a cleaner framework than a share-based offer. The basic trade is centered on the difference between the $123 cash consideration and the market price at which Synaptics shares trade, with that difference reflecting the market’s assessment of transaction uncertainty and timing. No closing date or approval status has been provided in the assignment, so the size and duration of any deal spread cannot be calculated here.

That discipline matters. A higher offer may improve the economics for $SYNA holders, but it does not eliminate the risks inherent in any announced transaction. The revised terms change the price; they do not, by themselves, establish when the deal will close or confirm that every condition has been satisfied. For traders, the relevant question is therefore not simply whether $123 looks attractive, but whether the spread adequately reflects the remaining uncertainty.

A Signal for Semiconductor M&A

This is also a sector signal. A major semiconductor consolidation deal, coupled with an explicit focus on immediate EPS accretion, suggests that M&A appetite remains active in the chip industry. Buyers are not necessarily pursuing scale for its own sake; they are also emphasizing the financial contribution that an acquisition may provide to shareholders.

The contrarian takeaway is that a higher bid is not automatically a better deal for the buyer. Onsemi’s revised offer may create greater value for Synaptics holders, while the accretion target is intended to justify the added consideration to Onsemi investors. The market’s final judgment will rest on whether those two objectives can coexist.